Does the media prefer KIDS or NNOX?

In the previous week, Nano-X Imaging had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 3 mentions for Nano-X Imaging and 2 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.06 beat Nano-X Imaging's score of 0.63 indicating that OrthoPediatrics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer NNOX or CLPT?

In the previous week, ClearPoint Neuro had 3 more articles in the media than Nano-X Imaging. MarketBeat recorded 6 mentions for ClearPoint Neuro and 3 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.63 beat ClearPoint Neuro's score of 0.31 indicating that Nano-X Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nano-X Imaging 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ClearPoint Neuro 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CARL or NNOX more profitable?

Carlsmed has a net margin of -57.76% compared to Nano-X Imaging's net margin of -790.87%. Carlsmed's return on equity of -60.74% beat Nano-X Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Carlsmed -57.76% -60.74% -29.84% Nano-X Imaging -790.87% -64.65% -57.27%

Nano-X Imaging (NNOX) Competitors

$1.82 -0.10 (-5.26%)

As of 10:14 AM Eastern

Compare

NNOX vs. KIDS, DCTH, CLPT, CV, and CARL

Should you buy Nano-X Imaging stock or one of its competitors? MarketBeat compares Nano-X Imaging with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Nano-X Imaging include OrthoPediatrics (KIDS), Delcath Systems (DCTH), ClearPoint Neuro (CLPT), CapsoVision (CV), and Carlsmed (CARL). These companies are all part of the "medical equipment" industry.

How does Nano-X Imaging compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, institutional ownership, valuation, profitability, media sentiment, analyst recommendations, earnings and dividends.

OrthoPediatrics presently has a consensus price target of $24.44, suggesting a potential upside of 45.33%. Nano-X Imaging has a consensus price target of $5.00, suggesting a potential upside of 174.88%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than OrthoPediatrics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.82
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are owned by institutional investors. 31.8% of OrthoPediatrics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

OrthoPediatrics has a net margin of -16.31% compared to Nano-X Imaging's net margin of -790.87%. OrthoPediatrics' return on equity of -7.01% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-16.31%	-7.01%	-4.86%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

In the previous week, Nano-X Imaging had 1 more articles in the media than OrthoPediatrics. MarketBeat recorded 3 mentions for Nano-X Imaging and 2 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 1.06 beat Nano-X Imaging's score of 0.63 indicating that OrthoPediatrics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

OrthoPediatrics has higher revenue and earnings than Nano-X Imaging. OrthoPediatrics is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	1.83	-$39.65M	-$1.68	N/A
Nano-X Imaging	$13.02M	9.72	-$75.02M	-$1.59	N/A

OrthoPediatrics has a beta of 1.03, indicating that its stock price is 3% more volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market.

Summary

OrthoPediatrics beats Nano-X Imaging on 9 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to Delcath Systems?

Delcath Systems (NASDAQ:DCTH) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

Delcath Systems has a net margin of 0.62% compared to Nano-X Imaging's net margin of -790.87%. Delcath Systems' return on equity of 0.51% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Delcath Systems	0.62%	0.51%	0.46%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

In the previous week, Nano-X Imaging had 2 more articles in the media than Delcath Systems. MarketBeat recorded 3 mentions for Nano-X Imaging and 1 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 1.89 beat Nano-X Imaging's score of 0.63 indicating that Delcath Systems is being referred to more favorably in the media.

Company	Overall Sentiment
Delcath Systems	Very Positive
Nano-X Imaging	Positive

Delcath Systems presently has a consensus target price of $22.50, suggesting a potential upside of 118.23%. Nano-X Imaging has a consensus target price of $5.00, suggesting a potential upside of 174.88%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Delcath Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Delcath Systems	2 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.43
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

Delcath Systems has higher revenue and earnings than Nano-X Imaging. Nano-X Imaging is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Delcath Systems	$85.23M	4.18	$2.70M	$0.01	1,031.00
Nano-X Imaging	$13.02M	9.72	-$75.02M	-$1.59	N/A

61.1% of Delcath Systems shares are held by institutional investors. Comparatively, 21.5% of Nano-X Imaging shares are held by institutional investors. 19.4% of Delcath Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Delcath Systems has a beta of 0.54, indicating that its stock price is 46% less volatile than the broader market. Comparatively, Nano-X Imaging has a beta of 1.21, indicating that its stock price is 21% more volatile than the broader market.

Summary

Delcath Systems beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to ClearPoint Neuro?

Nano-X Imaging (NASDAQ:NNOX) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

ClearPoint Neuro has higher revenue and earnings than Nano-X Imaging. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	9.72	-$75.02M	-$1.59	N/A
ClearPoint Neuro	$36.97M	10.53	-$25.54M	-$1.01	N/A

Nano-X Imaging presently has a consensus target price of $5.00, indicating a potential upside of 174.88%. ClearPoint Neuro has a consensus target price of $18.00, indicating a potential upside of 38.67%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, research analysts plainly believe Nano-X Imaging is more favorable than ClearPoint Neuro.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83
ClearPoint Neuro	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

21.5% of Nano-X Imaging shares are owned by institutional investors. Comparatively, 30.1% of ClearPoint Neuro shares are owned by institutional investors. 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

ClearPoint Neuro has a net margin of -71.57% compared to Nano-X Imaging's net margin of -790.87%. Nano-X Imaging's return on equity of -64.65% beat ClearPoint Neuro's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-790.87%	-64.65%	-57.27%
ClearPoint Neuro	-71.57%	-140.96%	-36.98%

In the previous week, ClearPoint Neuro had 3 more articles in the media than Nano-X Imaging. MarketBeat recorded 6 mentions for ClearPoint Neuro and 3 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.63 beat ClearPoint Neuro's score of 0.31 indicating that Nano-X Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nano-X Imaging	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ClearPoint Neuro	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nano-X Imaging has a beta of 1.21, suggesting that its stock price is 21% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, suggesting that its stock price is 31% more volatile than the broader market.

Summary

ClearPoint Neuro beats Nano-X Imaging on 11 of the 17 factors compared between the two stocks.

How does Nano-X Imaging compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, institutional ownership, profitability, analyst recommendations, earnings, dividends, risk and media sentiment.

In the previous week, Nano-X Imaging had 2 more articles in the media than CapsoVision. MarketBeat recorded 3 mentions for Nano-X Imaging and 1 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.87 beat Nano-X Imaging's score of 0.63 indicating that CapsoVision is being referred to more favorably in the media.

Company	Overall Sentiment
CapsoVision	Very Positive
Nano-X Imaging	Positive

21.5% of Nano-X Imaging shares are held by institutional investors. 2.3% of CapsoVision shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

CapsoVision presently has a consensus price target of $8.50, suggesting a potential upside of 21.60%. Nano-X Imaging has a consensus price target of $5.00, suggesting a potential upside of 174.88%. Given Nano-X Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Nano-X Imaging is more favorable than CapsoVision.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CapsoVision	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

CapsoVision has higher revenue and earnings than Nano-X Imaging. CapsoVision is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CapsoVision	$13.55M	25.77	-$25.32M	-$2.34	N/A
Nano-X Imaging	$13.02M	9.72	-$75.02M	-$1.59	N/A

CapsoVision has a net margin of -198.87% compared to Nano-X Imaging's net margin of -790.87%. CapsoVision's return on equity of 0.00% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CapsoVision	-198.87%	N/A	-136.03%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

Summary

Nano-X Imaging beats CapsoVision on 8 of the 15 factors compared between the two stocks.

How does Nano-X Imaging compare to Carlsmed?

Carlsmed (NASDAQ:CARL) and Nano-X Imaging (NASDAQ:NNOX) are both small-cap medical equipment companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk and earnings.

Carlsmed has a net margin of -57.76% compared to Nano-X Imaging's net margin of -790.87%. Carlsmed's return on equity of -60.74% beat Nano-X Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Carlsmed	-57.76%	-60.74%	-29.84%
Nano-X Imaging	-790.87%	-64.65%	-57.27%

In the previous week, Nano-X Imaging had 2 more articles in the media than Carlsmed. MarketBeat recorded 3 mentions for Nano-X Imaging and 1 mentions for Carlsmed. Carlsmed's average media sentiment score of 1.89 beat Nano-X Imaging's score of 0.63 indicating that Carlsmed is being referred to more favorably in the media.

Company	Overall Sentiment
Carlsmed	Very Positive
Nano-X Imaging	Positive

21.5% of Nano-X Imaging shares are held by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Carlsmed has higher revenue and earnings than Nano-X Imaging. Carlsmed is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Carlsmed	$56.44M	4.86	-$29.63M	-$2.51	N/A
Nano-X Imaging	$13.02M	9.72	-$75.02M	-$1.59	N/A

Carlsmed currently has a consensus target price of $19.33, suggesting a potential upside of 91.42%. Nano-X Imaging has a consensus target price of $5.00, suggesting a potential upside of 174.88%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Nano-X Imaging is more favorable than Carlsmed.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Carlsmed	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Nano-X Imaging	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	3 Strong Buy rating(s)	2.83

Summary

Nano-X Imaging beats Carlsmed on 8 of the 15 factors compared between the two stocks.

Get Nano-X Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NNOX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NNOX vs. The Competition

Export

Metric	Nano-X Imaging	Technology Services Industry	Business Sector	NASDAQ Exchange
Market Cap	$126.58M	$4.32B	$6.58B	$12.48B
Dividend Yield	N/A	1.99%	2.96%	5.30%
P/E Ratio	-1.14	47.92	29.80	24.35
Price / Sales	9.72	54.55	414.44	126.00
Price / Cash	N/A	41.97	24.63	57.88
Price / Book	0.90	5.03	5.94	6.72
Net Income	-$75.02M	$31.79M	$203.37M	$337.08M
7 Day Performance	-7.19%	2.62%	2.31%	1.63%
1 Month Performance	5.14%	1.96%	2.86%	6.29%
1 Year Performance	-65.74%	39.12%	41.91%	35.50%

Nano-X Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NNOX Nano-X Imaging	3.4128 of 5 stars	$1.82 -5.3%	$5.00 +174.9%	-63.3%	$126.58M	$13.02M	N/A	190	Gap Down
KIDS OrthoPediatrics	2.6827 of 5 stars	$18.37 flat	$24.44 +33.1%	-15.8%	$471.83M	$236.35M	N/A	200	Positive News
DCTH Delcath Systems	2.5459 of 5 stars	$11.02 flat	$22.50 +104.2%	-35.4%	$380.43M	$85.23M	1,102.00	60	Positive News
CLPT ClearPoint Neuro	3.0574 of 5 stars	$11.44 flat	$18.00 +57.3%	+4.9%	$343.09M	$36.97M	N/A	110	Gap Up
CV CapsoVision	1.8006 of 5 stars	$6.64 flat	$8.50 +28.0%	N/A	$331.76M	$13.55M	N/A	90

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NNOX) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Nano-X Imaging (NNOX) Competitors

NNOX vs. KIDS, DCTH, CLPT, CV, and CARL

How does Nano-X Imaging compare to OrthoPediatrics?

Summary

How does Nano-X Imaging compare to Delcath Systems?

Summary

How does Nano-X Imaging compare to ClearPoint Neuro?

Summary

How does Nano-X Imaging compare to CapsoVision?

Summary

How does Nano-X Imaging compare to Carlsmed?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Nano-X Imaging (NNOX) Competitors

NNOX vs. KIDS, DCTH, CLPT, CV, and CARL

How does Nano-X Imaging compare to OrthoPediatrics?

Do analysts rate KIDS or NNOX?

Do insiders and institutionals have more ownership in KIDS or NNOX?

Is KIDS or NNOX more profitable?

Does the media prefer KIDS or NNOX?

Which has higher earnings & valuation, KIDS or NNOX?

Which has more volatility and risk, KIDS or NNOX?

Summary

How does Nano-X Imaging compare to Delcath Systems?

Is DCTH or NNOX more profitable?

Does the media favor DCTH or NNOX?

Do analysts recommend DCTH or NNOX?

Which has stronger valuation and earnings, DCTH or NNOX?

Do institutionals & insiders have more ownership in DCTH or NNOX?

Which has more risk and volatility, DCTH or NNOX?

Summary

How does Nano-X Imaging compare to ClearPoint Neuro?

Which has preferable valuation and earnings, NNOX or CLPT?

Do analysts prefer NNOX or CLPT?

Do institutionals and insiders have more ownership in NNOX or CLPT?

Is NNOX or CLPT more profitable?

Does the media prefer NNOX or CLPT?

Which has more risk & volatility, NNOX or CLPT?

Summary

How does Nano-X Imaging compare to CapsoVision?

Does the media prefer CV or NNOX?

Do insiders and institutionals have more ownership in CV or NNOX?

Do analysts rate CV or NNOX?

Which has better valuation and earnings, CV or NNOX?

Is CV or NNOX more profitable?

Summary

How does Nano-X Imaging compare to Carlsmed?

Is CARL or NNOX more profitable?

Does the media refer more to CARL or NNOX?

Do insiders & institutionals have more ownership in CARL or NNOX?

Which has higher earnings & valuation, CARL or NNOX?

Do analysts rate CARL or NNOX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NNOX vs. The Competition

Nano-X Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools